| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/30/2001 | WO2001063286A2 Method for antigen-specific stimulation of t-lymphocytes with synthetic peptide libraries |
| 08/30/2001 | WO2001063284A2 Internal standards and controls for multiplexed assay |
| 08/30/2001 | WO2001063282A2 Analysis of biological targets using a biochip comprising a fluorescent marker |
| 08/30/2001 | WO2001063280A2 Inter-alpha-trypsin as a marker for sepsis |
| 08/30/2001 | WO2001063271A1 Electrochemical sensor for determining blood clotting, corresponding system for measuring blood clotting and method for determining blood clotting |
| 08/30/2001 | WO2001063263A1 Component comprising a plurality of fiber elements and sample molecules that are immobilized on said fiber elements |
| 08/30/2001 | WO2001063245A2 Method and apparatus for high throughput cell - based assays for screening and diagnostics |
| 08/30/2001 | WO2001063244A1 Solution and crystal structures of mmp-13 active site and uses thereof |
| 08/30/2001 | WO2001062984A2 Detection of human papilloma viruses |
| 08/30/2001 | WO2001062983A1 Improved methods for generating catalytic proteins |
| 08/30/2001 | WO2001062982A2 Methods for multi-stage solid phase amplification of nucleic acids |
| 08/30/2001 | WO2001062981A1 Platform for the discovery of the bacterial genes involved in rna modification |
| 08/30/2001 | WO2001062980A1 Methods for identifying a protease inhibitor |
| 08/30/2001 | WO2001062978A1 Screening methods for gram-positive enterococcal virulence factors |
| 08/30/2001 | WO2001062977A2 Methods and composition for diagnosing and treating pseudoxanthoma elasticum and related conditions |
| 08/30/2001 | WO2001062976A1 Rapid nucleic acid separation, isolation and purification methods |
| 08/30/2001 | WO2001062975A2 Pyrophosphorolysis activated polymerization (pap): application to allele-specific amplification and nucleic acid sequence determination |
| 08/30/2001 | WO2001062974A1 Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof |
| 08/30/2001 | WO2001062971A1 Detection of receptors for orphan ligands by retroviral display |
| 08/30/2001 | WO2001062969A2 Estrogen receptor alpha variants and methods of detection thereof |
| 08/30/2001 | WO2001062968A2 Mutant nucleic binding enzymes and use thereof in diagnostic, detection and purification methods |
| 08/30/2001 | WO2001062967A2 A method that compares genomic sequences |
| 08/30/2001 | WO2001062966A2 Methods for characterizing polymorphisms |
| 08/30/2001 | WO2001062965A2 Differential expression screening method |
| 08/30/2001 | WO2001062964A2 A genetic determinant for malignant melanoma |
| 08/30/2001 | WO2001062963A2 Method for immobilizing nucleic acids |
| 08/30/2001 | WO2001062962A2 Component for interaction analysis comprising probe molecule species which create co-operation effects |
| 08/30/2001 | WO2001062961A1 Ligase/polymerase method for detecting cytosine methylation in dna samples |
| 08/30/2001 | WO2001062960A2 Method for detecting cytosine methylation in dna samples |
| 08/30/2001 | WO2001062959A2 Endometriosis-related markers and uses thereof |
| 08/30/2001 | WO2001062956A1 Methods of screening for antimicrobial compounds |
| 08/30/2001 | WO2001062955A1 GENOMIC ANALYSIS OF tRNA GENE SETS |
| 08/30/2001 | WO2001062954A2 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 08/30/2001 | WO2001062953A2 Electrochemical method for detecting nucleic acids |
| 08/30/2001 | WO2001062952A1 Methods for determining single nucleotide variations |
| 08/30/2001 | WO2001062943A1 Topoisomerase linker-mediated amplification methods |
| 08/30/2001 | WO2001062940A2 New phosphodiesterase type 7b |
| 08/30/2001 | WO2001062935A1 A process for constructing dna based molecular marker for enabling selection of drought and diseases resistant germplasm screening |
| 08/30/2001 | WO2001062934A1 Starch branching enzyme |
| 08/30/2001 | WO2001062933A2 Muteins of interleukin-13 (il-13) |
| 08/30/2001 | WO2001062925A2 103p2d6: tissue specific protein highly expressed in various cancers |
| 08/30/2001 | WO2001062924A2 Human g protein-coupled receptors |
| 08/30/2001 | WO2001062923A2 Transporters and ion channels |
| 08/30/2001 | WO2001062914A1 Bcmp 84, a protein associated to breast cancer |
| 08/30/2001 | WO2001062905A2 Integrin antagonists |
| 08/30/2001 | WO2001062796A1 Ccr2-64i, polymorphic variant of the human ccrs receptor and its use in the diagnostic and treatment of atherosclerosis |
| 08/30/2001 | WO2001062795A1 COMPOUNDS RELATED TO OR DERIVED FROM GFRα4 AND THEIR USE |
| 08/30/2001 | WO2001062793A2 Estrogen receptor beta variants and methods of detection thereof |
| 08/30/2001 | WO2001062789A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | WO2001062784A2 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 08/30/2001 | WO2001062778A2 Tumour-specific animal proteins |
| 08/30/2001 | WO2001062770A1 Staphylococcal gtpase obgcleotide sequence encoding staphylococcal gtp-binding protein |
| 08/30/2001 | WO2001062377A2 Microarray fabrication techniques and apparatus |
| 08/30/2001 | WO2001062281A1 Pai-2 conjugates for the treatment and imaging of cancer |
| 08/30/2001 | WO2001062271A1 Compositions and methods for the early diagnosis of ovarian cancer |
| 08/30/2001 | WO2001062206A2 N-cadherin modulated migration, invasion, and metastasis |
| 08/30/2001 | WO2001062144A1 Method for transdermal sampling of analytes |
| 08/30/2001 | WO2001062064A2 Method for detecting cytosine methylation in dna samples |
| 08/30/2001 | WO2001025421A3 Materials and method for detecting interaction of cftr polypeptides |
| 08/30/2001 | WO2001016355A3 In vitro test system for gamma-secretase from enriched membranes |
| 08/30/2001 | WO2001016335A3 Stromelysin-homologous novel mmp-27 matrix metalloproteinase |
| 08/30/2001 | WO2001012847A3 Isolation of cells from forensic samples for dna-typing |
| 08/30/2001 | WO2001012823A3 Macular degeneration diagnostics and therapeutics |
| 08/30/2001 | WO2001012806A3 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 08/30/2001 | WO2001012776A3 18 human secreted proteins |
| 08/30/2001 | WO2001011333A3 Apparatus for real-time measurement of cellular response |
| 08/30/2001 | WO2001011083A3 Methods for detecting mutations using primer extension |
| 08/30/2001 | WO2001011077A3 Methods of diagnosing or treating irritable bowel syndrome and other disorders |
| 08/30/2001 | WO2001011039A3 New sequence variants of the human 1-adrenoreceptor gene and use thereof |
| 08/30/2001 | WO2001010900A3 Globular assembly of amyloid beta protein and uses thereof |
| 08/30/2001 | WO2001009325A3 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 08/30/2001 | WO2001007601A3 Method for conferring herbicide, pest, or disease resistance in plant hosts |
| 08/30/2001 | WO2001004358A3 Detection of anti-hepatitis b drug resistance |
| 08/30/2001 | WO2001002568A3 Human genes and gene expression products |
| 08/30/2001 | WO2001001142A3 Arrays of biopolymeric agents and method for their production and use |
| 08/30/2001 | WO2000077250A3 Method for circularizing oligonucleotides around a double stranded nucleic acid, resulting structures and uses thereof |
| 08/30/2001 | WO2000071729A3 Recombinant hosts suitable for simultaneous saccharification and fermentation |
| 08/30/2001 | WO2000050871A9 Microstructures for use in biological assays and reactions |
| 08/30/2001 | WO2000047983A9 Enzyme-linked immuno-magnetic electrochemical biosensor |
| 08/30/2001 | WO2000047738A9 Human and mouse trek-1 potassium channel protein and their use |
| 08/30/2001 | WO2000040733A9 Human cyclic nucleotide pdes |
| 08/30/2001 | WO2000040614A9 Characterization of the soc/crac calcium channel protein family |
| 08/30/2001 | US20010018642 Method and system for providing a probe array chip design database |
| 08/30/2001 | US20010018514 Nucleic acid labeling compounds |
| 08/30/2001 | US20010018511 Anticancer agent |
| 08/30/2001 | US20010018412 Primers specific to the target DNA fragment are immobilized on inner surfaces of the holes of a holder in a vessel; free primer common to the target DNA fragment species is mobile in the vessel with a solution and other reagents |
| 08/30/2001 | US20010018216 Dispensing biological reagents; spaced tandemly arranged substrates; conveyor belt; reagent transfer instrument; micropipette |
| 08/30/2001 | US20010018214 Culturing retrovirally infected eukaryotic cells in aseptic, low oxygen conditions; bacteria produced contain eukaryotic and viral genes |
| 08/30/2001 | US20010018208 Polynucleotide encoding polypeptide comprising fragment of mammalian aspartyl protease protein (Asp2) with beta-secretase activity; treatment of Alzheimer's disease |
| 08/30/2001 | US20010018206 Such as urea; enzymes (urease) added to biological fluid (milk, blood, urine); pressure monitor measures changes within vapor containing portion (partial pressure of carbon dioxide) |
| 08/30/2001 | US20010018200 Genetic engineering; using a glycosylated thiosulfonate |
| 08/30/2001 | US20010018198 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 08/30/2001 | US20010018195 Prevention cell death |
| 08/30/2001 | US20010018187 Coreactant-including electrochemiluminescent compounds, methods, systems and kits utilizing same |
| 08/30/2001 | US20010018186 Method for molecular diagnosis of tumor angiogenesis and metastasis |
| 08/30/2001 | US20010018185 Dna labeled with fluorescent dye |
| 08/30/2001 | US20010018184 Heterogenous assay for pyrophosphate |
| 08/30/2001 | US20010018183 Multicolor caomparative hybrid analysis |
| 08/30/2001 | US20010018182 Methods of monitoring disease states and therapies using gene expression profiles |
| 08/30/2001 | US20010018181 Determination mutants |